Compumedics Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
David Burton
Chief executive officer
AU$253.4k
Total compensation
| CEO salary percentage | 90.1% |
| CEO tenure | 37.9yrs |
| CEO ownership | 53.4% |
| Management average tenure | no data |
| Board average tenure | 8yrs |
Recent management updates
This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate
Oct 24
Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year
Oct 19Recent updates
This Is Why Compumedics Limited's (ASX:CMP) CEO Compensation Looks Appropriate
Oct 24Further Upside For Compumedics Limited (ASX:CMP) Shares Could Introduce Price Risks After 38% Bounce
Jun 17Returns On Capital Signal Difficult Times Ahead For Compumedics (ASX:CMP)
Mar 07We Think Compumedics (ASX:CMP) Has A Fair Chunk Of Debt
Nov 03Is Compumedics (ASX:CMP) A Risky Investment?
May 27Compumedics (ASX:CMP) Could Be At Risk Of Shrinking As A Company
Jan 25Some Shareholders May Object To A Pay Rise For Compumedics Limited's (ASX:CMP) CEO This Year
Oct 19Compumedics (ASX:CMP) Seems To Use Debt Quite Sensibly
Oct 14Is Compumedics (ASX:CMP) Using Debt Sensibly?
May 02Compumedics (ASX:CMP) May Have Issues Allocating Its Capital
Dec 08Compumedics (ASX:CMP) Will Want To Turn Around Its Return Trends
Aug 09Here's Why Compumedics (ASX:CMP) Has A Meaningful Debt Burden
Jun 10Returns On Capital Signal Tricky Times Ahead For Compumedics (ASX:CMP)
May 06These 4 Measures Indicate That Compumedics (ASX:CMP) Is Using Debt Extensively
Feb 25How Much Did Compumedics'(ASX:CMP) Shareholders Earn From Share Price Movements Over The Last Year?
Dec 01CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | AU$253k | AU$228k | -AU$338k |
| Mar 31 2024 | n/a | n/a | AU$447k |
| Dec 31 2023 | n/a | n/a | AU$1m |
| Sep 30 2023 | n/a | n/a | -AU$2m |
| Jun 30 2023 | AU$252k | AU$228k | -AU$6m |
| Mar 31 2023 | n/a | n/a | -AU$6m |
| Dec 31 2022 | n/a | n/a | -AU$6m |
| Sep 30 2022 | n/a | n/a | -AU$2m |
| Jun 30 2022 | AU$251k | AU$228k | AU$1m |
| Mar 31 2022 | n/a | n/a | AU$663k |
| Dec 31 2021 | n/a | n/a | -AU$31k |
| Sep 30 2021 | n/a | n/a | AU$484k |
| Jun 30 2021 | AU$244k | AU$223k | AU$998k |
| Mar 31 2021 | n/a | n/a | -AU$2m |
| Dec 31 2020 | n/a | n/a | -AU$5m |
| Sep 30 2020 | n/a | n/a | -AU$5m |
| Jun 30 2020 | AU$237k | AU$217k | -AU$6m |
| Mar 31 2020 | n/a | n/a | -AU$1m |
| Dec 31 2019 | n/a | n/a | AU$3m |
| Sep 30 2019 | n/a | n/a | AU$4m |
| Jun 30 2019 | AU$250k | AU$228k | AU$4m |
| Mar 31 2019 | n/a | n/a | AU$3m |
| Dec 31 2018 | n/a | n/a | AU$3m |
| Sep 30 2018 | n/a | n/a | AU$3m |
| Jun 30 2018 | AU$250k | AU$228k | AU$3m |
Compensation vs Market: David's total compensation ($USD157.78K) is below average for companies of similar size in the Australian market ($USD291.73K).
Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.
CEO
David Burton (65 yo)
37.9yrs
Tenure
AU$253,391
Compensation
Dr. David Burton, Ph.D. founded Compumedics Ltd. in 1987 and serves as its Executive Chairman and Chief Executive Officer. Dr. Burton serves as Executive Chairman and Chief Executive Officer of Compumedics...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | no data | AU$253.39k | 53.45% A$ 26.0m | |
| CFO, Company Secretary & Executive Director | 11.2yrs | AU$389.91k | 1.89% A$ 919.7k | |
| Non-Executive Director | 2.2yrs | AU$30.00k | 0.0011% A$ 530.8 | |
| Member of Medical Advisory Board | 8yrs | no data | no data | |
| Member of Medical Advisory Board | 8yrs | no data | no data | |
| Member of Medical Advisory Board | 8yrs | no data | no data |
8.0yrs
Average Tenure
Experienced Board: CMP's board of directors are considered experienced (8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/20 10:40 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Compumedics Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ian Martin | New Street Research LLP |
| Paul Jensz | PAC Partners Securities Pty. Ltd. |
| Stephen Scott | Taylor Collison Limited |